Labeler
NorthStar RxLLC NDC Codes
NorthStar RxLLC lists 301 finished drug products in the FDA NDC Directory under NDC labeler codes 16714, 72603.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine Sodium, Atomoxetine, Pregabalin, Dasatinib, Doxepin Hydrochloride, Atorvastatin calcium, Nebivolol, lurasidone hydrochloride, Lidocaine hydrochloride, Bupivacaine Hydrochloride, Olmesartan medoxomil, Sacubitril and Valsartan, Midodrine Hydrochloride, Venlafaxine Hydrochloride, Irbesartan
- Active ingredients
- Levothyroxine sodium, Atomoxetine hydrochloride, Pregabalin, Dasatinib, Doxepin hydrochloride, Atorvastatin calcium trihydrate, Nebivolol hydrochloride, Lurasidone hydrochloride, Lidocaine hydrochloride anhydrous, Bupivacaine hydrochloride, Olmesartan medoxomil, Sacubitril
- NDC labeler codes
- 16714, 72603
- Strengths (from the 100 most recently listed products)
- Lidocaine hydrochloride anhydrous 10 mg/mL; Lidocaine hydrochloride anhydrous 20 mg/mL; Bupivacaine hydrochloride 5 mg/mL; Bupivacaine hydrochloride 7.5 mg/mL; Ticagrelor 60 mg/1; Ticagrelor 90 mg/1; Olmesartan medoxomil 40 mg/1; Olmesartan medoxomil 5 mg/1; Olmesartan medoxomil 20 mg/1; Sacubitril 97 mg/1; Valsartan 103 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Midodrine hydrochloride 2.5 mg/1; Midodrine hydrochloride 5 mg/1; Midodrine hydrochloride 10 mg/1; Rivaroxaban 2.5 mg/1; Venlafaxine hydrochloride 37.5 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Injection, Solution, Capsule, Extended release, Solution/ drops, Ointment, Solution, Suppository, Powder, For suspension, Tablet, Delayed release, Injection, Powder, Lyophilized, For solution
- Routes
- Oral, Perineural, Infiltration, Epidural, Topical, Ophthalmic, Intracaudal, Retrobulbar, Rectal, Intravenous, Subcutaneous
- Drug classes (FDA established)
- Angiotensin 2 Receptor Blocker, l-Thyroxine, Amide Local Anesthetic, Kinase Inhibitor, Norepinephrine Reuptake Inhibitor, HMG-CoA Reductase Inhibitor, beta-Adrenergic Blocker, Tricyclic Antidepressant, Atypical Antipsychotic, Antiarrhythmic, Neprilysin Inhibitor, alpha-Adrenergic Agonist, Serotonin and Norepinephrine Reuptake Inhibitor, Corticosteroid, Glinide, P2Y12 Platelet Inhibitor, Peroxisome Proliferator Receptor alpha Agonist, Osmotic Laxative, alpha-1 Adrenergic Agonist, Factor Xa Inhibitor, Nonsteroidal Anti-inflammatory Drug, Direct Thrombin Inhibitor, Calculi Dissolution Agent, Phosphate Binder, Nucleoside Metabolic Inhibitor, Aminosalicylate, Proteasome Inhibitor, mTOR Inhibitor Immunosuppressant
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 147 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Nebivolol | Nebivolol hydrochloride 2.5 mg/1 | TabletOral | 72603-870 | 72603-0870-01 | — |
| Nebivolol | Nebivolol hydrochloride 5 mg/1 | TabletOral | 72603-871 | 72603-0871-0172603-0871-02 | — |
| Nebivolol | Nebivolol hydrochloride 10 mg/1 | TabletOral | 72603-872 | 72603-0872-0172603-0872-02 | — |
| Nebivolol | Nebivolol hydrochloride 20 mg/1 | TabletOral | 72603-873 | 72603-0873-0172603-0873-02 | — |
| Fluocinonide | Fluocinonide .5 mg/mL | SolutionTopical | 72603-703 | 72603-0703-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 10 mg/1 | CapsuleOral | 72603-390 | 72603-0390-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 100 mg/1 | CapsuleOral | 72603-394 | 72603-0394-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 25 mg/1 | CapsuleOral | 72603-391 | 72603-0391-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 50 mg/1 | CapsuleOral | 72603-392 | 72603-0392-01 | — |
| Doxepin Hydrochloride | Doxepin hydrochloride 75 mg/1 | CapsuleOral | 72603-393 | 72603-0393-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 72603-624 | 72603-0624-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 72603-621 | 72603-0621-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 72603-622 | 72603-0622-01 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 72603-623 | 72603-0623-01 | — |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/1 | TabletOral | 72603-664 | 72603-0664-0172603-0664-0272603-0664-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 50 ug/1 | TabletOral | 72603-661 | 72603-0661-0172603-0661-0272603-0661-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 75 ug/1 | TabletOral | 72603-662 | 72603-0662-0172603-0662-0272603-0662-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 88 ug/1 | TabletOral | 72603-663 | 72603-0663-0172603-0663-0272603-0663-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 150 ug/1 | TabletOral | 72603-668 | 72603-0668-0172603-0668-0272603-0668-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 112 ug/1 | TabletOral | 72603-665 | 72603-0665-0172603-0665-0272603-0665-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 125 ug/1 | TabletOral | 72603-666 | 72603-0666-0172603-0666-0272603-0666-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 137 ug/1 | TabletOral | 72603-667 | 72603-0667-0172603-0667-0272603-0667-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 175 ug/1 | TabletOral | 72603-669 | 72603-0669-0172603-0669-0272603-0669-11 | — |
| Levothyroxine Sodium | Levothyroxine sodium 200 ug/1 | TabletOral | 72603-701 | 72603-0701-0172603-0701-0272603-0701-11 | — |
| Repaglinide | Repaglinide .5 mg/1 | TabletOral | 72603-810 | 72603-0810-01 | — |
| Repaglinide | Repaglinide 1 mg/1 | TabletOral | 72603-811 | 72603-0811-01 | — |
| Repaglinide | Repaglinide 2 mg/1 | TabletOral | 72603-812 | 72603-0812-01 | — |
| Levothyroxine Sodium | Levothyroxine sodium 25 ug/1 | TabletOral | 72603-660 | 72603-0660-0172603-0660-0272603-0660-11 | — |
| Triamcinolone acetonide | Triamcinolone acetonide 1 mg/g | OintmentTopical | 16714-276 | 16714-0276-0116714-0276-0216714-0276-03 | — |
| Sodium sulfate, potassium sulfate and magnesium sulfate | Sodium sulfate 17.5 g/177mL + 2 more ingredients | SolutionOral | 72603-278 | 72603-0278-02 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-732 | 72603-0732-25 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-722 | 72603-0722-25 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-744 | 72603-0744-25 | — |
| Lidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | 72603-825 | 72603-0825-1072603-0825-25 | — |
| Candesartan | Candesartan cilexetil 16 mg/1 | TabletOral | 72603-720 | 72603-0720-01 | — |
| Candesartan | Candesartan cilexetil 32 mg/1 | TabletOral | 72603-721 | 72603-0721-01 | — |
| Sevelamer Carbonate | Sevelamer carbonate .8 g/1 | Powder, For suspensionOral | 72603-398 | 72603-0398-02 | — |
| pitavastatin calcium | Pitavastatin calcium 2.09 mg/1 | Tablet, Film coatedOral | 72603-479 | 72603-0479-01 | — |
| pitavastatin calcium | Pitavastatin calcium 4.18 mg/1 | Tablet, Film coatedOral | 72603-480 | 72603-0480-01 | — |
| timolol maleate | Timolol maleate 5 mg/mL | Solution/ dropsOphthalmic | 72603-540 | 72603-0540-01 | — |
| capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 72603-303 | 72603-0303-01 | — |
| Mesalamine | Mesalamine 1.2 g/1 | Tablet, Delayed releaseOral | 72603-304 | 72603-0304-01 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 72603-270 | 72603-0270-01 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 25 mg/mL | Solution/ dropsOphthalmic | 72603-520 | 72603-0520-0172603-0520-02 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 72603-506 | 72603-0506-1072603-0506-25 | — |
| Phenylephrine Hydrochloride | Phenylephrine hydrochloride 100 mg/mL | Solution/ dropsOphthalmic | 72603-530 | 72603-0530-01 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 5 mg/mL | Injection, SolutionEpidural, Intracaudal, Perineural | 72603-602 | 72603-0602-25 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Retrobulbar | 72603-700 | 72603-0700-1072603-0700-25 | — |
| Bupivacaine Hydrochloride | Bupivacaine hydrochloride 7.5 mg/mL | Injection, SolutionEpidural, Retrobulbar | 72603-800 | 72603-0800-25 | — |
| Everolimus | Everolimus 2.5 mg/1 | TabletOral | 72603-254 | 72603-0254-01 | — |
NorthStar RxLLC: common questions
- What is NorthStar RxLLC's NDC labeler code?
- 16714, 72603. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for NorthStar RxLLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.